588 related articles for article (PubMed ID: 7792436)
21. Regulation of human airway surface liquid.
Widdicombe JH; Widdicombe JG
Respir Physiol; 1995 Jan; 99(1):3-12. PubMed ID: 7740210
[TBL] [Abstract][Full Text] [Related]
22. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
Lethem MI; James SL; Marriott C
Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological approaches to discovery and development of new mucolytic agents.
King M; Rubin BK
Adv Drug Deliv Rev; 2002 Dec; 54(11):1475-90. PubMed ID: 12458156
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
Griese M; App EM; Duroux A; Burkert A; Schams A
Pulm Pharmacol Ther; 1997; 10(1):21-7. PubMed ID: 9344829
[TBL] [Abstract][Full Text] [Related]
25. Mucins, mucus, and sputum.
Voynow JA; Rubin BK
Chest; 2009 Feb; 135(2):505-512. PubMed ID: 19201713
[TBL] [Abstract][Full Text] [Related]
26. Development of an airway mucus defect in the cystic fibrosis rat.
Birket SE; Davis JM; Fernandez CM; Tuggle KL; Oden AM; Chu KK; Tearney GJ; Fanucchi MV; Sorscher EJ; Rowe SM
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321377
[TBL] [Abstract][Full Text] [Related]
27. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacology of mucociliary transport].
Lurie A; Pascal O; Castillon du Perron M; Grandordy B; Huchon G; Chrétien J
Rev Mal Respir; 1985; 2(3):117-26. PubMed ID: 4081277
[TBL] [Abstract][Full Text] [Related]
29. Distearoyl phosphatidylglycerol liposomes improve surface and transport properties of CF mucus.
Girod de Bentzmann S; Pierrot D; Fuchey C; Zahm JM; Morançais JL; Puchelle E
Eur Respir J; 1993 Sep; 6(8):1156-61. PubMed ID: 8224130
[TBL] [Abstract][Full Text] [Related]
30. Mechanosensitive ATP release maintains proper mucus hydration of airways.
Button B; Okada SF; Frederick CB; Thelin WR; Boucher RC
Sci Signal; 2013 Jun; 6(279):ra46. PubMed ID: 23757023
[TBL] [Abstract][Full Text] [Related]
31. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions.
Zahm JM; Debordeaux C; Maurer C; Hubert D; Dusser D; Bonnet N; Lazarus RA; Puchelle E
Am J Respir Crit Care Med; 2001 Apr; 163(5):1153-7. PubMed ID: 11316652
[TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
Henderson AG; Ehre C; Button B; Abdullah LH; Cai LH; Leigh MW; DeMaria GC; Matsui H; Donaldson SH; Davis CW; Sheehan JK; Boucher RC; Kesimer M
J Clin Invest; 2014 Jul; 124(7):3047-60. PubMed ID: 24892808
[TBL] [Abstract][Full Text] [Related]
33. Effects of methylxanthines on airway mucociliary function.
Wanner A
Am J Med; 1985 Dec; 79(6A):16-21. PubMed ID: 3002175
[TBL] [Abstract][Full Text] [Related]
34. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
[TBL] [Abstract][Full Text] [Related]
35. Airway Epithelial Differentiation and Mucociliary Clearance.
Whitsett JA
Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S143-S148. PubMed ID: 30431340
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the depth and composition of airway surface liquid.
Widdicombe JH
J Anat; 2002 Oct; 201(4):313-8. PubMed ID: 12430955
[TBL] [Abstract][Full Text] [Related]
37. Mucus Hyperconcentration as a Unifying Aspect of the Chronic Bronchitic Phenotype.
Button B; Anderson WH; Boucher RC
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2(Suppl 2):S156-62. PubMed ID: 27115951
[TBL] [Abstract][Full Text] [Related]
38. [Pathologic bronchial secretions and mucociliary transport].
Puchelle E
Ann Anesthesiol Fr; 1980; 21(6):661-6. PubMed ID: 6111274
[TBL] [Abstract][Full Text] [Related]
39. [Physiology and pathophysiology of bronchial secretion].
Ficker JH
Pneumologie; 2008 Mar; 62 Suppl 1():S11-3. PubMed ID: 18317975
[TBL] [Abstract][Full Text] [Related]
40. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
